Loading…
Loading…
Myeloma bone disease: from biology findings to treatment approaches
Terpos, Evangelos, Ntanasis-Stathopoulos, Ioannis, Dimopoulos, Meletios A.
Published in Blood (04.04.2019)
Published in Blood (04.04.2019)
Get full text
Journal Article
Loading…
Hematological findings and complications of COVID‐19
Terpos, Evangelos, Ntanasis‐Stathopoulos, Ioannis, Elalamy, Ismail, Kastritis, Efstathios, Sergentanis, Theodoros N., Politou, Marianna, Psaltopoulou, Theodora, Gerotziafas, Grigoris, Dimopoulos, Meletios A.
Published in American journal of hematology (01.07.2020)
Published in American journal of hematology (01.07.2020)
Get full text
Journal Article
Loading…
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
Trougakos, Ioannis P., Terpos, Evangelos, Alexopoulos, Harry, Politou, Marianna, Paraskevis, Dimitrios, Scorilas, Andreas, Kastritis, Efstathios, Andreakos, Evangelos, Dimopoulos, Meletios A.
Published in Trends in molecular medicine (01.07.2022)
Published in Trends in molecular medicine (01.07.2022)
Get full text
Journal Article
Loading…
Recent advances in the management of AL Amyloidosis
Kastritis, Efstathios, Dimopoulos, Meletios A.
Published in British journal of haematology (01.01.2016)
Published in British journal of haematology (01.01.2016)
Get full text
Journal Article
Loading…
Organ-specific manifestations of COVID-19 infection
Gavriatopoulou, Maria, Korompoki, Eleni, Fotiou, Despina, Ntanasis-Stathopoulos, Ioannis, Psaltopoulou, Theodora, Kastritis, Efstathios, Terpos, Evangelos, Dimopoulos, Meletios A.
Published in Clinical and experimental medicine (01.11.2020)
Published in Clinical and experimental medicine (01.11.2020)
Get full text
Journal Article
Loading…
Loading…
Treatment options for relapsed and refractory multiple myeloma
Nooka, Ajay K., Kastritis, Efstathios, Dimopoulos, Meletios A., Lonial, Sagar
Published in Blood (14.05.2015)
Published in Blood (14.05.2015)
Get full text
Journal Article
Loading…
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
Trougakos, Ioannis P., Stamatelopoulos, Kimon, Terpos, Evangelos, Tsitsilonis, Ourania E., Aivalioti, Evmorfia, Paraskevis, Dimitrios, Kastritis, Efstathios, Pavlakis, George N., Dimopoulos, Meletios A.
Published in Journal of biomedical science (12.01.2021)
Published in Journal of biomedical science (12.01.2021)
Get full text
Journal Article
Loading…
Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients
Bergamaschi, Cristina, Terpos, Evangelos, Rosati, Margherita, Angel, Matthew, Bear, Jenifer, Stellas, Dimitris, Karaliota, Sevasti, Apostolakou, Filia, Bagratuni, Tina, Patseas, Dimitris, Gumeni, Sentiljana, Trougakos, Ioannis P., Dimopoulos, Meletios A., Felber, Barbara K., Pavlakis, George N.
Published in Cell reports (Cambridge) (10.08.2021)
Published in Cell reports (Cambridge) (10.08.2021)
Get full text
Journal Article
Loading…
Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma
Dimopoulos, Meletios A, Dytfeld, Dominik, Grosicki, Sebastian, Moreau, Philippe, Takezako, Naoki, Hori, Mitsuo, Leleu, Xavier, LeBlanc, Richard, Suzuki, Kenshi, Raab, Marc S, Richardson, Paul G, Popa McKiver, Mihaela, Jou, Ying-Ming, Shelat, Suresh G, Robbins, Michael, Rafferty, Brian, San-Miguel, Jesús
Published in The New England journal of medicine (08.11.2018)
Published in The New England journal of medicine (08.11.2018)
Get full text
Journal Article
Loading…
Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Final Overall Survival Analysis From the Randomized Phase II ELOQUENT-3 Trial
Dimopoulos, Meletios A., Dytfeld, Dominik, Grosicki, Sebastian, Moreau, Philippe, Takezako, Naoki, Hori, Mitsuo, Leleu, Xavier, LeBlanc, Richard, Suzuki, Kenshi, Raab, Marc S., Richardson, Paul G., Popa McKiver, Mihaela, Jou, Ying-Ming, Yao, David, Das, Prianka, San-Miguel, Jesús
Published in Journal of Clinical Oncology (20.01.2023)
Published in Journal of Clinical Oncology (20.01.2023)
Get full text
Journal Article
Loading…
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study
Dimopoulos, Meletios A, Moreau, Philippe, Palumbo, Antonio, Joshua, Douglas, Pour, Ludek, Hájek, Roman, Facon, Thierry, Ludwig, Heinz, Oriol, Albert, Goldschmidt, Hartmut, Rosiñol, Laura, Straub, Jan, Suvorov, Aleksandr, Araujo, Carla, Rimashevskaya, Elena, Pika, Tomas, Gaidano, Gianluca, Weisel, Katja, Goranova-Marinova, Vesselina, Schwarer, Anthony, Minuk, Leonard, Masszi, Tamás, Karamanesht, Ievgenii, Offidani, Massimo, Hungria, Vania, Spencer, Andrew, Orlowski, Robert Z, Gillenwater, Heidi H, Mohamed, Nehal, Feng, Shibao, Chng, Wee-Joo
Published in The lancet oncology (01.01.2016)
Published in The lancet oncology (01.01.2016)
Get full text
Journal Article
Loading…
Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study
Bahlis, Nizar J., Dimopoulos, Meletios A., White, Darrell J., Benboubker, Lotfi, Cook, Gordon, Leiba, Merav, Ho, P. Joy, Kim, Kihyun, Takezako, Naoki, Moreau, Philippe, Kaufman, Jonathan L., Krevvata, Maria, Chiu, Christopher, Qin, Xiang, Okonkwo, Linda, Trivedi, Sonali, Ukropec, Jon, Qi, Ming, San-Miguel, Jesus
Published in Leukemia (01.07.2020)
Published in Leukemia (01.07.2020)
Get full text
Journal Article
Loading…
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
Palladini, Giovanni, Dispenzieri, Angela, Gertz, Morie A., Kumar, Shaji, Wechalekar, Ashutosh, Hawkins, Philip N., Schönland, Stefan, Hegenbart, Ute, Comenzo, Raymond, Kastritis, Efstathios, Dimopoulos, Meletios A., Jaccard, Arnaud, Klersy, Catherine, Merlini, Giampaolo
Published in Journal of clinical oncology (20.12.2012)
Published in Journal of clinical oncology (20.12.2012)
Get full text
Journal Article
Loading…
Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia
Dimopoulos, Meletios A, Tedeschi, Alessandra, Trotman, Judith, García-Sanz, Ramón, Macdonald, David, Leblond, Veronique, Mahe, Beatrice, Herbaux, Charles, Tam, Constantine, Orsucci, Lorella, Palomba, M. Lia, Matous, Jeffrey V, Shustik, Chaim, Kastritis, Efstathios, Treon, Steven P, Li, Jianling, Salman, Zeena, Graef, Thorsten, Buske, Christian
Published in The New England journal of medicine (21.06.2018)
Published in The New England journal of medicine (21.06.2018)
Get full text
Journal Article
Loading…
Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review
Korompoki, Eleni, Gavriatopoulou, Maria, Hicklen, Rachel S, Ntanasis-Stathopoulos, Ioannis, Kastritis, Efstathios, Fotiou, Despina, Stamatelopoulos, Kimon, Terpos, Evangelos, Kotanidou, Anastasia, Hagberg, Carin A, Dimopoulos, Meletios A, Kontoyiannis, Dimitrios P
Published in The Journal of infection (01.07.2021)
Published in The Journal of infection (01.07.2021)
Get full text
Journal Article
Loading…
Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study
Moreau, Philippe, Mateos, Maria-Victoria, Berenson, James R, Weisel, Katja, Lazzaro, Antonio, Song, Kevin, Dimopoulos, Meletios A, Huang, Mei, Zahlten-Kumeli, Anita, Stewart, A Keith
Published in The lancet oncology (01.07.2018)
Published in The lancet oncology (01.07.2018)
Get full text
Journal Article
Loading…
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 4‐year follow‐up and analysis of relative progression‐free survival from the randomized ELOQUENT‐2 trial
Dimopoulos, Meletios A., Lonial, Sagar, Betts, Keith A., Chen, Clara, Zichlin, Miriam L., Brun, Alexander, Signorovitch, James E., Makenbaeva, Dinara, Mekan, Sabeen, Sy, Oumar, Weisel, Katja, Richardson, Paul G.
Published in Cancer (15.10.2018)
Published in Cancer (15.10.2018)
Get full text
Journal Article
Loading…
Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE
San-Miguel, Jesus, Avet-Loiseau, Hervé, Paiva, Bruno, Kumar, Shaji, Dimopoulos, Meletios A., Facon, Thierry, Mateos, María-Victoria, Touzeau, Cyrille, Jakubowiak, Andrzej, Usmani, Saad Z., Cook, Gordon, Cavo, Michele, Quach, Hang, Ukropec, Jon, Ramaswami, Priya, Pei, Huiling, Qi, Mia, Sun, Steven, Wang, Jianping, Krevvata, Maria, DeAngelis, Nikki, Heuck, Christoph, Van Rampelbergh, Rian, Kudva, Anupa, Kobos, Rachel, Qi, Ming, Bahlis, Nizar J.
Published in Blood (27.01.2022)
Published in Blood (27.01.2022)
Get full text
Journal Article